| Primary |
| Glaucoma |
54.1% |
| Open Angle Glaucoma |
17.4% |
| Ocular Hypertension |
7.9% |
| Intraocular Pressure Increased |
6.6% |
| Hypertension |
1.7% |
| Normal Tension Glaucoma |
1.7% |
| Angle Closure Glaucoma |
1.2% |
| Cardiac Disorder |
1.2% |
| Diabetes Mellitus |
1.2% |
| Scotoma |
1.2% |
| Hiv Infection |
0.8% |
| Ocular Hyperaemia |
0.8% |
| Osteoarthritis |
0.8% |
| Type 2 Diabetes Mellitus |
0.8% |
| Age-related Macular Degeneration |
0.4% |
| Benign Prostatic Hyperplasia |
0.4% |
| Cataract |
0.4% |
| Dementia Alzheimer's Type |
0.4% |
| Depression |
0.4% |
| Gastric Disorder |
0.4% |
|
| Visual Acuity Reduced |
20.6% |
| Cystoid Macular Oedema |
8.2% |
| Intraocular Pressure Increased |
7.2% |
| Drug Ineffective |
6.2% |
| Bradycardia |
4.1% |
| Dyspnoea |
4.1% |
| Ocular Hyperaemia |
4.1% |
| Palpitations |
4.1% |
| Skin Hyperpigmentation |
4.1% |
| Tinnitus |
4.1% |
| Trichiasis |
4.1% |
| Vision Blurred |
4.1% |
| Anosmia |
3.1% |
| Arrhythmia |
3.1% |
| Asthmatic Crisis |
3.1% |
| Eye Pruritus |
3.1% |
| Hallucination, Visual |
3.1% |
| Hypersensitivity |
3.1% |
| Macular Oedema |
3.1% |
| Papilloedema |
3.1% |
|
| Secondary |
| Glaucoma |
41.8% |
| Product Used For Unknown Indication |
7.3% |
| Hypertension |
6.6% |
| Open Angle Glaucoma |
5.8% |
| Intraocular Pressure Increased |
5.1% |
| Age-related Macular Degeneration |
3.9% |
| Hiv Infection |
3.9% |
| Ocular Hypertension |
3.6% |
| Drug Use For Unknown Indication |
3.2% |
| Blood Cholesterol Increased |
2.7% |
| Eye Disorder |
2.4% |
| Asthma |
1.9% |
| Hypothyroidism |
1.9% |
| Osteoporosis |
1.7% |
| Abdominal Pain Upper |
1.5% |
| Blood Triglycerides Increased |
1.5% |
| Postoperative Care |
1.5% |
| Anxiety |
1.2% |
| Cataract |
1.2% |
| Depression |
1.2% |
|
| Ocular Hyperaemia |
11.4% |
| Hypertrophic Cardiomyopathy |
10.2% |
| Visual Impairment |
10.2% |
| Intraocular Pressure Increased |
6.8% |
| Upper Limb Fracture |
6.8% |
| Vision Blurred |
6.8% |
| Urinary Tract Infection |
5.7% |
| Eye Irritation |
4.5% |
| Muscular Weakness |
4.5% |
| Visual Acuity Reduced |
4.5% |
| Cataract |
3.4% |
| Diarrhoea |
3.4% |
| Drug Hypersensitivity |
3.4% |
| Photopsia |
3.4% |
| Tremor |
3.4% |
| Acute Generalised Exanthematous Pustulosis |
2.3% |
| Asthma |
2.3% |
| Eye Disorder |
2.3% |
| Gynaecomastia |
2.3% |
| Hallucination |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.5% |
| Drug Use For Unknown Indication |
18.3% |
| Glaucoma |
17.8% |
| Hypertension |
8.0% |
| Pain |
3.5% |
| Osteoporosis |
3.3% |
| Atrial Fibrillation |
3.1% |
| Rheumatoid Arthritis |
2.7% |
| Depression |
2.6% |
| Asthma |
2.4% |
| Diabetes Mellitus |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Blood Cholesterol Increased |
2.2% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Prophylaxis |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
| Multiple Myeloma |
1.5% |
| Arthritis |
1.2% |
| Blood Pressure |
1.2% |
| Intraocular Pressure Increased |
1.1% |
|
| Vomiting |
13.9% |
| Weight Decreased |
8.7% |
| Death |
6.5% |
| Visual Acuity Reduced |
6.3% |
| Vision Blurred |
5.7% |
| Myocardial Infarction |
5.4% |
| Intraocular Pressure Increased |
4.9% |
| Dyspnoea |
4.4% |
| Urinary Tract Infection |
4.4% |
| Drug Ineffective |
4.1% |
| Headache |
3.8% |
| Transient Ischaemic Attack |
3.8% |
| Eye Irritation |
3.5% |
| Nausea |
3.5% |
| Oedema Peripheral |
3.5% |
| Product Quality Issue |
3.5% |
| Somnolence |
3.5% |
| Visual Impairment |
3.5% |
| Weight Increased |
3.5% |
| Fatigue |
3.3% |
|
